{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:10:27Z","timestamp":1783199427032,"version":"3.54.6"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejim.2014.12.002","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T04:18:23Z","timestamp":1420431503000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9448-6739","authenticated-orcid":false,"given":"Xingshun","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejim.2014.12.002_bb0005","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.ejim.2014.12.002_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.ejim.2014.12.002_bb0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2000.16597","article-title":"Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy","volume":"32","author":"Condat","year":"2000","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"11","key":"10.1016\/j.ejim.2014.12.002_bb0020","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1538-7836.2006.01887.x","article-title":"Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes","volume":"4","author":"Reverter","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2010.01.005","article-title":"The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes","volume":"21","author":"Basili","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2014.12.002_bb0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0040","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejim.2010.02.001","article-title":"The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No","volume":"21","author":"Tripodi","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1538-7836.2006.01886.x","article-title":"Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No","volume":"4","author":"Mannucci","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.ejim.2014.12.002_bb0060","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1538-7836.2006.02103.x","article-title":"Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No, but they need a careful look","volume":"4","author":"Matsushita","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ejim.2014.12.002_bb0065","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/S0168-8278(14)60694-2","article-title":"Natural course of total portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Girleanu","year":"2014","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0070","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1665-2681(19)31301-8","article-title":"Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis","volume":"12","author":"John","year":"2013","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2014.12.002_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2014.12.002_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MAJ.0b013e31826485fc","article-title":"Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis","volume":"346","author":"Qi","year":"2013","journal-title":"Am J Med Sci"},{"issue":"11","key":"10.1016\/j.ejim.2014.12.002_bb0095","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.cgh.2014.04.026","article-title":"Associations of coagulation factor V leiden and prothrombin G20210A mutations with Budd\u2013Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis","volume":"12","author":"Qi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"14","key":"10.1016\/j.ejim.2014.12.002_bb0100","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1111\/hepr.12348","article-title":"Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd\u2013Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis of observational studies","volume":"44","author":"Qi","year":"2014","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MBC.0b013e328285d822","article-title":"Treatment of extensive subacute portal, mesenteric and ileocolic vein thrombosis with recombinant tissue plasminogen activator","volume":"18","author":"Hrstic","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejim.2014.12.002_bb0110","first-page":"s8","article-title":"Baseline characteristics and management of patients with splanchnic vein thrombosis: results of an international registry","volume":"10","author":"Ageno","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.ejim.2014.12.002_bb0115","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/S1590-8658(11)60505-7","article-title":"Portal vein thrombosis in cirrhotic and noncirrhotic patients. Role of anticoagulation therapy","volume":"43","author":"Debernardi","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejim.2014.12.002_bb0120","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.crad.2012.06.013","article-title":"Radiological reporting of incidental portal vein thrombosis \u2014 do we aid clinical management?","volume":"67","author":"Gopalan","year":"2012","journal-title":"Clin Radiol"},{"issue":"9","key":"10.1016\/j.ejim.2014.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1365-2036.2010.04454.x","article-title":"The epidemiology and clinical features of portal vein thrombosis: a multicentre study","volume":"32","author":"Rajani","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2014.12.002_bb0130","first-page":"950","article-title":"Asian patients with splanchnic vein thrombosis: a subanalysis from an international registry","volume":"11","author":"Riva","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2014.12.002_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"7","author":"Sogaard","year":"2007","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.12037","article-title":"Portal vein thrombosis \u2014 experience in a single centre","volume":"159","author":"Swallow","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.diii.2014.02.018","article-title":"Computed tomography follow-up of acute portal vein thrombosis","volume":"95","author":"Attali","year":"2014","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2014.12.002_bb0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00261-011-9795-9","article-title":"Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound","volume":"37","author":"Maruyama","year":"2012","journal-title":"Abdom Imaging"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0160","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/00365521.2012.674972","article-title":"Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding","volume":"47","author":"Maruyama","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejim.2014.12.002_bb0165","first-page":"266","article-title":"Portal vein thrombosis in cirrhotic patients: safety and efficacy of low dosage of enoxaparin","volume":"4","author":"Pellicelli","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejim.2014.12.002_bb0170","first-page":"1267A","article-title":"Portal vein thrombosis (PVT) in patients with liver cirrhosis: outcome of screening and anticoagulation","volume":"54","author":"Aqel","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.ejim.2014.12.002_bb0175","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/S1590-8658(13)60485-5","article-title":"Clinical outcome of partial portal vein thrombosis in cirrhotic patients: to observe or to treat?","volume":"45","author":"Caracciolo","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejim.2014.12.002_bb0180","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0168-8278(13)60237-8","article-title":"Predictors of response to anticoagulant therapy for the treatment of portal vein thrombosis (PVT) in cirrhosis patients","volume":"58","author":"Rodriguez-Castro","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2014.12.002_bb0185","first-page":"S201","article-title":"Management of portal and splancnic vein thrombosis in patients awaiting liver transplantation (LT)","volume":"15","author":"Senzolo","year":"2009","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11739-008-0219-y","article-title":"Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered","volume":"4","author":"Senzolo","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2014.12.002_bb0195","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1016\/S0168-8278(11)60938-0","article-title":"Portal vein thrombosis affects prognosis of cirrhotic patients with previous variceal haemorrhage","volume":"54","author":"Amitrano","year":"2011","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"21","key":"10.1016\/j.ejim.2014.12.002_bb0205","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.3358.3358","article-title":"Antithrombotic therapy in non-neoplastic chronic portal venous thrombosis in cirrhosis: recanalization and liver function evaluation","volume":"118","author":"Bento","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2014.12.002_bb0210","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S1590-8658(10)60465-3","article-title":"Anticoagulant treatment for not neoplastic portal vein thrombosis in patients with liver cirrhosis and esophageal varices","volume":"42","author":"Butera","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0215","first-page":"867A","article-title":"Anticoagulant therapy with sulodexidum for portal vein thrombosis in patients with liver cirrhosis","volume":"58","author":"Copaci","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"7","key":"10.1016\/j.ejim.2014.12.002_bb0220","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.dld.2013.08.138","article-title":"Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation","volume":"46","author":"Dell'Era","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.ejim.2014.12.002_bb0230","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2014.12.002_bb0235","first-page":"1261A","article-title":"Clinical outcome of portal vein thrombosis (PVT) in cirrhotic patients: observe or treat?","volume":"54","author":"Garcovich","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.ejim.2014.12.002_bb0240","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00007890-201407151-02404","article-title":"Risk factors for death on the waiting list for liver transplantation in patients with non-malignant portal vein thrombosis","volume":"98","author":"Iacob","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2014.12.002_bb0245","first-page":"1263A","article-title":"Danaparoid sodium was effective for portal vein thrombosis independent of plasma antithrombin III level","volume":"54","author":"Imamura","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.ejim.2014.12.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.12400","article-title":"Efficacy and safety of anticoagulant drug, danaparoid sodium, for the treatment of portal vein thrombosis in patients with liver cirrhosis","author":"Naeshiro","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ejim.2014.12.002_bb0255","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.dld.2014.01.093","article-title":"Liver transplantation in cirrhotic patients with portal vein thrombosis: a single centre experience","volume":"46","author":"Risso","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0260","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.ejim.2014.12.002_bb0265","first-page":"894A","article-title":"Danaparoid sodium monotherapy for portal vein thrombosis in cirrhotic patients is as effective as combination therapy with antithrombin III","volume":"58","author":"Takatori","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"10.1016\/j.ejim.2014.12.002_bb0270","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation","volume":"58","author":"Werner","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.ejim.2014.12.002_bb0275","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1517\/14656561003749264","article-title":"Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients?","volume":"11","author":"Ponziani","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.ejim.2014.12.002_bb0280","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.amjmed.2010.03.019","article-title":"Anticoagulation for portal vein thrombosis in cirrhosis","volume":"123","author":"Qi","year":"2010","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ejim.2014.12.002_bb0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/187152511797037448","article-title":"Anticoagulants in cirrhotic patients: controversies and certainties in PVT management","volume":"9","author":"Ponziani","year":"2011","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"1","key":"10.1016\/j.ejim.2014.12.002_bb0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2011.12.034","article-title":"Portal vein thrombosis, cirrhosis, and liver transplantation","volume":"57","author":"Francoz","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2014.12.002_bb0295","doi-asserted-by":"crossref","first-page":"672986","DOI":"10.1155\/2012\/672986","article-title":"Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review","volume":"2012","author":"Huard","year":"2012","journal-title":"Int J Hepatol"},{"issue":"10","key":"10.1016\/j.ejim.2014.12.002_bb0300","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1478-3231.2012.02839.x","article-title":"Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis","volume":"32","author":"Rodriguez-Castro","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0305","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11894-012-0306-0","article-title":"Portal vein thrombosis: should anticoagulation be used?","volume":"15","author":"Congly","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.ejim.2014.12.002_bb0310","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12072-013-9427-2","article-title":"Role of anticoagulant therapy in liver disease","volume":"7","author":"Plompen","year":"2013","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.ejim.2014.12.002_bb0315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrgastro.2014.36","article-title":"Management of portal vein thrombosis in liver cirrhosis","volume":"11","author":"Qi","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2014.12.002_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2013.12.003","article-title":"Portal vein thrombosis in cirrhosis","author":"Raja","year":"2014","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"10.1016\/j.ejim.2014.12.002_bb0325","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.cgh.2012.02.015","article-title":"Degree of portal vein thrombosis might be associated with recanalization during anticoagulation","volume":"10","author":"Qi","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ejim.2014.12.002_bb0330","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/hep.23397","article-title":"Degree of portal vein thrombosis","volume":"51","author":"Qi","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.ejim.2014.12.002_bb0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/1319-3767.141680","article-title":"Spontaneous resolution of portal vein thrombosis in liver cirrhosis: where do we stand, and where will we do?","volume":"20","author":"Qi","year":"2014","journal-title":"Saudi J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejim.2014.12.002_bb0340","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1148\/radiol.12122259","article-title":"Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat?","volume":"266","author":"Qi","year":"2013","journal-title":"Radiology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514003562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514003562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T23:05:57Z","timestamp":1650927957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514003562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0953620514003562"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.12.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}